PATENT CLAIM ANALYSIS

Application Number: 15570051
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "669000"]

Abstract:
In some embodiments, the invention includes therapeutic combinations of antiviral active pharmaceutical ingredients and anti-inflammatory active pharmaceutical ingredients, including steroids, and methods of using of the therapeutic compositions in the treatment of viral infections.

Claim (Index 24):
The method of  claim 23 , wherein the treating nearly completely resolves the signs and symptoms of adenoviral conjunctivitis.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 91.0
- Lexical Diversity: 1.46154
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10616046', '13607472', '15370611', '11401805', '14623772']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7104531468605119
- 35 USC 102 Novelty (BERT): 0.5024616310147773
- Combined Prediction Score: 0.6896539952759384
- Mean Citation Score: 150.032798
- Max Citation Score: 163.4532
- Similarity Product: 92.51634030904768

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test